NUK - logo
E-viri
Celotno besedilo
Recenzirano Odprti dostop
  • Low sensitivity of commerci...
    Korošec, Peter, PhD; Valenta, Rudolf, MD; Mittermann, Irene, PhD; Čelesnik, Nina, BS; Eržen, Renato, MD; Zidarn, Mihaela, MD; Košnik, Mitja, PhD, MD

    Journal of allergy and clinical immunology, 09/2011, Letnik: 128, Številka: 3
    Journal Article

    Because this recombinant is potentially very useful and commercially available, we wanted to evaluate its diagnostic utility and compare it with the nApi m 1 allergen in a routine clinical laboratory setting by analyzing a large group of patients with well-defined honeybee venom allergy before adopting its use in our clinical practices.